Journal Club
Open Access Article

Perspectives of Postmenopausal Breast Cancer Survivors on Adjuvant Endocrine Therapy-Related Symptoms

G.J. van Londen

Heidi S. Donovan

Ellen B. Beckjord

Alexandra L. Cardy

Dana H. Bovbjerg

Nancy E. Davidson

Jennifer Q. Morse

Galen E. Switzer

Irma M. Verdonck-de Leeuw

Mary Amanda Dew

breast cancer, quality of life, adjuvant endocrine therapy
ONF 2014, 41(6), 660-668. DOI: 10.1188/14.ONF.660-668

Purpose/Objectives: To conduct an investigation of women's experiences related to adjuvant endocrine therapy (AET) and managing AET-related symptoms.

Research Approach: Qualitative, focus group design.

Setting: Main campus of the University of Pittsburgh in Pennsylvania.

Participants: 14 breast cancer survivors, aged 50 years or older, with AET-related symptoms.

Methodologic Approach: Semistructured discussion guides were used to elicit recollections of conversations with healthcare providers about starting AET, symptom experiences, symptom management, and suggestions for improving management. Audiotaped discussions were transcribed and analyzed to identify themes.

Findings: Women reported that, initially, AET was not viewed as a choice, but rather as the necessary next step to save their lives. After starting AET, women experienced difficulties making sense of, communicating about, and managing unanticipated AET-related symptoms. Women who experienced persistently bothersome symptoms began weighing the pros and cons of AET to decide whether to continue treatment.

Conclusions: Focus group findings suggest multiple opportunities to better prepare patients for AET and to improve assessment and management of AET-related symptoms.

Interpretation: By exploring AET-related symptom experiences, nurses may be able to promote AET adherence in breast cancer survivors.

Jump to a section


    Aiello Bowles, E. J., Boudreau, D. M., Chubak, J., Yu, O., Fujii, M., Chestnut, J., & Buist, D. S. (2012). Patient-reported discontinuation of endocrine therapy and related adverse effects among women with early-stage breast cancer. Journal of Oncology Practice, 8, e149-e157. doi:10.1200/JOP.2012.000543
    Amir, E., Seruga, B., Niraula, S., Carlsson, L., & Ocana, A. (2011). Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: A systematic review and meta-analysis. Journal of the National Cancer Institute, 103, 1299-1309. doi:10.1093/jnci/djr242
    Baumeister, H., Balke, K., & Harter, M. (2005). Psychiatric and somatic comorbidities are negatively associated with quality of life in physically ill patients. Journal of Clinical Epidemiology, 58, 1090-1100. doi:10.1016/j.jclinepi.2005.03.011
    Beekman, A. T., Smit, F., Stek, M. L., Reynolds, C. F., III, & Cuijpers, P. C. (2010). Preventing depression in high-risk groups. Current Opinion in Psychiatry, 23, 8-11. doi:10.1097/YCO.0b013e328333e17f
    Bender, C. M., Gentry, A. L., Brufsky, A. M., Casillo, F. E., Cohen, S. M., Dailey, M. M., … Sereika, S. M. (2014). Influence of patient and treatment factors on adherence to adjuvant endocrine therapy in breast cancer. Oncology Nursing Forum, 41, 274-285. doi:10.1188/ONF.14.274-285
    Blumel, J. E., Castelo-Branco, C., Binfa, L., Gramegna, G., Tacla, X., Aracena, B., … Sanjuan, A. (2000). Quality of life after the menopause: A population study. Maturitas, 34, 17-23.
    Burstein, H. J., Prestrud, A. A., Seidenfeld, J., Anderson, H., Buchholz, T. A., Davidson, N. E., … Griggs, J. J. (2010). American Society of Clinical Oncology clinical practice guideline: Update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. Journal of Clinical Oncology, 28, 3784-3796.
    Burstein, H. J., Temin, S., Anderson, H., Buchholz, T. A., Davidson, N. E., Gelmon, K. E., … Griggs, J. J. (2014). Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: American Society of Clinical Oncology clinical practice guideline focused update. Journal of Clinical Oncology. Advance online publication. doi:10.1200/JCO.2013.54.2258
    Cella, D., Fallowfield, L., Barker, P., Cuzick, J., Locker, G., & Howell, A. (2006). Quality of life of postmenopausal women in the ATAC ("Arimidex," tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for early breast cancer. Breast Cancer Research and Treatment, 100, 273-284. doi:10.1007/s10549-006-9260-6
    Chedraui, P., San Miguel, G., & Avila, C. (2009). Quality of life impairment during the female menopausal transition is related to personal and partner factors. Gynecological Endocrinology, 25, 130-135. doi:10.1080/09513590802617770
    Christensen, A. J. (2000). Patient-by-treatment context interaction in chronic disease: A conceptual framework for the study of patient adherence. Psychosomatic Medicine, 62, 435-443.
    Cluze, C., Rey, D., Huiart, L., Bendiane, M. K., Bouhnik, A. D., Berenger, C., … Giorgi, R. (2011). Adjuvant endocrine therapy with tamoxifen in young women with breast cancer: Determinants of interruptions vary over time. Annals of Oncology, 23, 882-890. doi:10.1093/annonc/mdr330
    Conde, D. M., Pinto-Neto, A. M., Cabello, C., Sa, D. S., Costa-Paiva, L., & Martinez, E. Z. (2005). Menopause symptoms and quality of life in women aged 45 to 65 years with and without breast cancer. Menopause, 12, 436-443. doi:10.1097/01.GME.0000151655.10243.48
    Cuijpers, P., Beekman, A. T., & Reynolds, C. F., III. (2012). Preventing depression: A global priority. JAMA, 307, 1033-1034. doi:10.1001/jama.2012.271
    Davies, C., Pan, H., Godwin, J., Gray, R., Arriagada, R., Raina, V., … Peto, R. (2012). Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet, 9869, 805-816. doi:10.1016/S0140-6736(12)61963-1
    Feldman-Stewart, D., Madarnas, Y., Mates, M., Tong, C., Grunfeld, E., Verma, S., … Brundage, M. (2013). Information for decision making by post-menopausal women with hormone receptor positive early-stage breast cancer considering adjuvant endocrine therapy. Breast, 22, 919-925. doi:10.1016/j.breast.2013.04.020
    Fink, A. K., Gurwitz, J., Rakowski, W., Guadagnoli, E., & Silliman, R. A. (2004). Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor-positive breast cancer. Journal of Clinical Oncology, 22, 3309-3315. doi:10.1200/JCO.2004.11.06422/16/3309
    Fontein, D. B., Seynaeve, C., Hadji, P., Hille, E. T., van de Water, W., Putter, H., … van de Velde, C. J. (2013). Specific adverse events predict survival benefit in patients treated with tamoxifen or aromatase inhibitors: An international tamoxifen exemestane adjuvant multinational trial analysis. Journal of Clinical Oncology, 31, 2257-2264. doi:10.1200/JCO.2012.45.3068
    Ganz, P. A., Rowland, J. H., Desmond, K., Meyerowitz, B. E., & Wyatt, G. E. (1998). Life after breast cancer: Understanding women's health-related quality of life and sexual functioning. Journal of Clinical Oncology, 16, 501-514.
    Gupta, P., Sturdee, D. W., Palin, S. L., Majumder, K., Fear, R., Marshall, T., & Paterson, I. (2006). Menopausal symptoms in women treated for breast cancer: The prevalence and severity of symptoms and their perceived effects on quality of life. Climacteric, 9, 49-58. doi:10.1080/13697130500487224
    Hagan, T. L., & Donovan, H. S. (2013). Ovarian cancer survivors' experiences of self-advocacy: A focus group study. Oncology Nursing Forum, 40, 140-147. doi:10.1188/13.ONF.A12-A19
    Henry, N. L., Azzouz, F., Desta, Z., Li, L., Nguyen, A. T., Lemler, S., … Storniolo, A. M. (2012). Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancer. Journal of Clinical Oncology, 30, 936-942. doi:10.1200/JCO.2011.38.0261
    Hershman, D. L., Kushi, L. H., Shao, T., Buono, D., Kershenbaum, A., Tsai, W. Y., … Neugut, A. I. (2010). Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. Journal of Clinical Oncology, 28, 4120-4128. doi:10.1200/JCO.2009.25.9655
    Hershman, D. L., Shao, T., Kushi, L. H., Buono, D., Tsai, W. Y., Fehrenbacher, L., … Neugut, A. I. (2011). Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Research and Treatment, 126, 529-537. doi:10.1007/s10549-010-1132-4
    Hickey, M., Saunders, C., Partridge, A., Santoro, N., Joffe, H., & Stearns, V. (2008). Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer. Annals of Oncology, 19, 1669-1680. doi:10.1093/annonc/mdn353
    Krebber, A. M., Leemans, C. R., de Bree, R., van Straten, A., Smit, F., Smit, E. F., … Verdonck-de Leeuw, I. M. (2012). Stepped care targeting psychological distress in head and neck and lung cancer patients: A randomized clinical trial. BMC Cancer, 12, 173. doi:10.1186/1471-2407-12-173
    Kuzel, A. J. (1992). Sampling in qualitative inquiry. In B. F. Crabtree & W. F. Miller (Eds.), Doing qualitative research. Research methods for primary care (vol. 3, pp. 31-44). Thousand Oaks, CA: Sage.
    Land, S. R., Wickerham, D. L., Costantino, J. P., Ritter, M. W., Vogel, V. G., Lee, M., … Ganz, P. A. (2006). Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA, 295, 2742-2751. doi:10.1001/jama.295.23.joc60075
    Loh, S. Y., Packer, T., Chinna, K., & Quek, K. F. (2013). Effectiveness of a patient self-management programme for breast cancer as a chronic illness: A non-randomised controlled clinical trial. Journal of Cancer Survivorship, 7, 331-342. doi:10.1007/s11764-013-0274-x
    Morse, J. M. (2000). Determining sample size. Qualitative Health Research, 10, 3-5. doi:10.1177/104973200129118183
    Morse J. M. (2008) Confusing categories and themes. Qualitative Health Research, 18, 727-728. doi:10.1177/1049732308314930
    Motl, R. W., & McAuley, E. (2010). Physical activity, disability, and quality of life in older adults. Physical Medicine and Rehabilitation Clinics of North America, 21, 299-308. doi:10.1016/j.pmr.2009.12.006
    Murphy, C. C., Bartholomew, L. K., Carpentier, M. Y., Bluethmann, S. M., & Vernon, S. W. (2012). Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: A systematic review. Breast Cancer Research and Treatment, 134, 459-478. doi:10.1007/s10549-012-2114-5
    Partridge, A. H., Wang, P. S., Winer, E. P., & Avorn, J. (2003). Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. Journal of Clinical Oncology, 21, 602-606.
    Patton, M. Q. (2002). Qualitative research and evaluation methods. Thousand Oaks, CA: Sage.
    Perry, S., Kowalski, T. L., & Chang, C. H. (2007). Quality of life assessment in women with breast cancer: Benefits, acceptability and utilization. Health and Quality of Life Outcomes, 5, 24.
    Rechis, R., Boerner, L., Nutt, S., Shaw, K., Berno, D., & Duchover, Y. (2010). How cancer has affected post-treatment survivors: A LiveStrong report. Retrieved from
    Riegel, B., Moser, D. K., Anker, S. D., Appel, L. J., Dunbar, S. B., Grady, K. L., … Whellan, D. J. (2009). State of the science: Promoting self-care in persons with heart failure: A scientific statement from the American Heart Association. Circulation, 120, 1141-1163.
    Ryan, G. W., & Bernard, H. R. (2003). Techniques to identify themes. Field Methods, 15, 85-109. doi:10.1177/1525822x02239569
    Schwarz, S., Volzke, H., Alte, D., Schwahn, C., Grabe, H. J., Hoffmann, W., … Doren, M. (2007). Menopause and determinants of quality of life in women at midlife and beyond: The Study of Health in Pomerania (SHIP). Menopause, 14, 123-134. doi:10.1097/01.gme.0000227860.58097.e9
    Stanton, A. L., Bernaards, C. A., & Ganz, P. A. (2005). The BCPT symptom scales: A measure of physical symptoms for women diagnosed with or at risk for breast cancer. Journal of the National Cancer Institute, 97, 448-456. doi:10.1093/jnci/dji069
    Stearns, V., & Hayes, D. F. (2002). Approach to menopausal symptoms in women with breast cancer. Current Treatment Options in Oncology, 3, 179-190.
    Stein, K. D., Jacobsen, P. B., Hann, D. M., Greenberg, H., & Lyman, G. (2000). Impact of hot flashes on quality of life among postmenopausal women being treated for breast cancer. Journal of Pain and Symptom Management, 19, 436-445.
    Strauss, A. C., & Corbin, J. M. (1990). Basics of qualitative research: Grounded theory procedures and techniques (2nd ed.). Newbury Park, CA: Sage.
    van Londen, G., Beckjord, E. B., Dew, M. A., Cuijpers, P., Tadic, S., & Brufsky, A. (2013). Breast cancer survivorship symptom management: Current perspective and future development. Breast Cancer Management, 2, 71-81.
    Wilson I. B., & Cleary, P. D. (1995) Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA, 273, 59-65.
    Wrosch, C., & Sabiston, C. M. (2012). Goal adjustment, physical and sedentary activity, and well-being and health among breast cancer survivors. Psycho-Oncology, 22, 581-589. doi:10.1002/pon.3037